106 related articles for article (PubMed ID: 6406608)
1. Cell mediated lympholysis; a modified technique using 111indium-oxine-labelled targets.
Jakubek P; Thorsby E; Hirschberg H
J Immunol Methods; 1983 Jun; 60(3):379-90. PubMed ID: 6406608
[TBL] [Abstract][Full Text] [Related]
2. Assessment of in vivo natural antitumor resistance and lymphocyte. Migration in mice: comparison of 125I-iododeoxyuridine with 111indium-oxine and 51chromium as cell labels.
Wiltrout RH; Gorelik E; Brunda MJ; Holden HT; Herberman RB
Cancer Immunol Immunother; 1983; 14(3):172-9. PubMed ID: 6404550
[TBL] [Abstract][Full Text] [Related]
3. Measurements of cell-mediated cytotoxicity on target cells labelled with the indium-111-oxine complex.
Smet-Donnay M; Guillaume M; Schaaf-Lafontaine N; Czichosz R; Firket H
Ann Biol Clin (Paris); 1985; 43(3):285-8. PubMed ID: 3161437
[TBL] [Abstract][Full Text] [Related]
4. Measurement of macrophage-mediated cytotoxicity against adherent and non-adherent target cells by release of 11 indium-oxine.
Wiltrout RH; Taramelli D; Holden HT
J Immunol Methods; 1981; 43(3):319-31. PubMed ID: 6788853
[TBL] [Abstract][Full Text] [Related]
5. Platelet regeneration time after aspirin ingestion and platelet survival time after labelling with 51chromium or 111indium oxine--a comparative study.
Boneu A; Sié P; Bugat R; Caranobe C; Eber M; Cazenave JP; Boneu B
Thromb Haemost; 1985 Apr; 53(2):260-3. PubMed ID: 3927506
[TBL] [Abstract][Full Text] [Related]
6. Isolation of granulocytes and labelling with indium 111-oxine sulphate.
Pfeiffer G; Erten J; Deubelbeiss K
Eur J Nucl Med; 1982; 7(5):195-6. PubMed ID: 7094920
[TBL] [Abstract][Full Text] [Related]
7. Kinetics of indium-oxine labelled red cells in haemolytic anaemias.
Najean Y; Pommier Y; Deschryver F; Chomienne C
Eur J Nucl Med; 1986; 12(8):379-80. PubMed ID: 3098565
[TBL] [Abstract][Full Text] [Related]
8. An isotope release cytotoxicity assay applicable to human tumors: the use of 111indium.
Frost P; Wiltrout R; Maciorowski Z; Rose NR
Oncology; 1977; 34(3):102-4. PubMed ID: 917438
[TBL] [Abstract][Full Text] [Related]
9. Restrictions to the use of 111 indium-oxine as a radiolabel in lymphocyte migration studies.
Van Dinther-Janssen AC; Scheper RJ
J Immunol Methods; 1981; 46(3):353-60. PubMed ID: 6796624
[TBL] [Abstract][Full Text] [Related]
10. 111In-oxine labelling of tumour-cytotoxic macrophages generated in vitro from circulating blood monocytes: an in vitro evaluation.
Marienhagen J; Hennemann B; Andreesen R; Eilles C
Nucl Med Commun; 1995 May; 16(5):357-61. PubMed ID: 7659388
[TBL] [Abstract][Full Text] [Related]
11. 111Indium labeling of cultured human tumor cells.
Lockshin A; Mendoza JT; Giovanella BC; Stehlin JS
Oncology; 1985; 42(5):322-7. PubMed ID: 3929199
[TBL] [Abstract][Full Text] [Related]
12. Comparison of three different methods for radiolabelling human activated T lymphocytes.
Botti C; Negri DR; Seregni E; Ramakrishna V; Arienti F; Maffioli L; Lombardo C; Bogni A; Pascali C; Crippa F; Massaron S; Remonti F; Nerini-Molteni S; Canevari S; Bombardieri E
Eur J Nucl Med; 1997 May; 24(5):497-504. PubMed ID: 9142729
[TBL] [Abstract][Full Text] [Related]
13. [In vitro and in vivo studies using 111 indium oxine, 111 indium oxine sulfate and 99m Tc oxine in erythrocyte labeling].
Reiter S; Angelberger P; Kolbe H; Sinzinger H
Wien Klin Wochenschr; 1984 Feb; 96(3):120-3. PubMed ID: 6426172
[TBL] [Abstract][Full Text] [Related]
14. Comparison of three platelet markers for measurement of platelet survival time in healthy volunteers.
Dewanjee MK; Wahner HW; Dunn WL; Robertson JS; Offord KP; Fuster VD; Chesebro JH
Mayo Clin Proc; 1986 May; 61(5):327-36. PubMed ID: 3084883
[TBL] [Abstract][Full Text] [Related]
15. Intrahepatic kinetics of indium-111-labelled platelets.
Peters AM; Saverymuttu SH; Malik F; Ind PW; Lavender JP
Thromb Haemost; 1985 Oct; 54(3):595-8. PubMed ID: 3937258
[TBL] [Abstract][Full Text] [Related]
16. [111In]oxine labelling of polymorphonuclear leucocytes: doubts concerning elution and effects on cell behaviour.
Sheehan NJ; Brown KA; Camacho A; Dumonde DC
Int J Nucl Med Biol; 1985; 12(3):243-7. PubMed ID: 3934095
[TBL] [Abstract][Full Text] [Related]
17. Labelling of lymphocytes with indium 111 oxine: effect on cell surface phenotype and antibody-dependent cellular cytotoxicity.
Signore A; Beales P; Sensi M; Zuccarini O; Pozzilli P
Immunol Lett; 1983 Mar; 6(3):151-4. PubMed ID: 6407981
[TBL] [Abstract][Full Text] [Related]
18. The use of indium-111 for studies of cytotoxicity mediated by lymphocytes or by antibodies and complement.
Ferluga J; Allison AC; Thakur ML
J Clin Lab Immunol; 1979 Feb; 1(4):339-42. PubMed ID: 501729
[TBL] [Abstract][Full Text] [Related]
19. Preparation of a viable population of indium-111-labelled human blood platelets.
Heyns AD; Badenhorst PN; Pieters H; Lötter MG; Minnaar PC; Duyvené de Wit LJ; Van Reenen OR; Retief FP
Thromb Haemost; 1980 Feb; 42(5):1473-82. PubMed ID: 6768151
[TBL] [Abstract][Full Text] [Related]
20. Isotope-release cytotoxicity assay with the use of indium-111: advantage over chromium-51 in long-term assays.
Wiltrout RH; Frost P; Cummings GD
J Natl Cancer Inst; 1978 Jul; 61(1):183-8. PubMed ID: 97392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
